Process mapping of the urgent red cell exchange procedure for patients with severe complications of sickle cell disease at a centralized hemapheresis service

被引:1
作者
Smith, Jacob A. [1 ]
Seheult, Jansen N. [1 ,2 ]
Sevcik, Joan [2 ]
Kiss, Joseph E. [2 ,3 ]
Kaplan, Alesia [1 ,2 ]
机构
[1] Univ Pittsburgh, Med Ctr, Dept Pathol, 3636 Blvd Allies, Pittsburgh, PA 15213 USA
[2] Vitalant, Dept Clin Apheresis, Pittsburgh, PA USA
[3] Univ Pittsburgh, Dept Med, Med Ctr, Div Hematol Oncol, Pittsburgh, PA USA
关键词
red cell exchange; process mapping; centralized hemapheresis service; AMERICAN SOCIETY; ALLOIMMUNIZATION; TRANSFUSION; APHERESIS;
D O I
10.1002/jca.21823
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sickle cell disease (SCD) patients require urgent red cell exchange (RCE) procedures for acute chest syndrome (ACS), demanding a coordinated effort of multiple clinical services. Execution of RCE is a multistep process from the time the procedure is requested to the time the procedure is initiated. A retrospective review of patients with SCD requiring urgent RCE for ACS and stroke from 2012 to 2017 was performed at a centralized hemapheresis service covering a multihospital healthcare system. A total of 30 urgent RCE procedures performed on 28 patients were evaluated. The time required for red blood cell (RBC) preparation was the longest step in the process (median 3.8 hours). Furthermore, RBC preparation time was longer for sickle cell patients with RBC alloimmunization compared with nonalloimmunized patients (8.6 vs 3.8 hours,P= .03). One mortality event occurred in Ab- group. This study identified potentially modifiable factors, which impact the time to implementation of RCE in one service area. It highlights the importance of a structured and coordinated approach for the efficient and timely delivery of this vital treatment modality.
引用
收藏
页码:427 / 434
页数:8
相关论文
共 12 条
[1]   Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions [J].
Aygun, B ;
Padmanabhan, S ;
Paley, C ;
Chandrasekaran, V .
TRANSFUSION, 2002, 42 (01) :37-43
[2]  
Brown D, 1998, TRANSFUSION, V28, P21
[3]   High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors [J].
Chou, Stella T. ;
Jackson, Tannoa ;
Vege, Sunitha ;
Smith-Whitley, Kim ;
Friedman, David F. ;
Westhoff, Connie M. .
BLOOD, 2013, 122 (06) :1062-1071
[4]   Alloimmunization in patients with sickle cell disease and underrecognition of accompanying delayed hemolytic transfusion reactions [J].
Coleman, Sarita ;
Westhoff, Connie M. ;
Friedman, David F. ;
Chou, Stella T. .
TRANSFUSION, 2019, 59 (07) :2282-2291
[5]   Mortality Rates and Age at Death from Sickle Cell Disease: US, 1979-2005 [J].
Lanzkron, Sophie ;
Carroll, C. Patrick ;
Haywood, Carlton, Jr. .
PUBLIC HEALTH REPORTS, 2013, 128 (02) :110-116
[6]   Causes of Death in Sickle Cell Disease Adult Patients: Old and New Trends [J].
Ngo, Stephanie ;
Bartolucci, Pablo ;
Lobo, David ;
Mekontso-Dessap, Armand ;
Gellen-Dautremer, Justine ;
Noizat-Pirenne, France ;
Audard, Vincent ;
Godeau, Bertrand ;
Galacteros, Frederic ;
Habibi, Anoosha .
BLOOD, 2014, 124 (21)
[7]   Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue [J].
Padmanabhan, Anand ;
Connelly-Smith, Laura ;
Aqui, Nicole ;
Balogun, Rasheed A. ;
Klingel, Reinhard ;
Meyer, Erin ;
Pham, Huy P. ;
Schneiderman, Jennifer ;
Witt, Volker ;
Wu, Yanyun ;
Zantek, Nicole D. ;
Dunbar, Nancy M. ;
Schwartz, Joseph .
JOURNAL OF CLINICAL APHERESIS, 2019, 34 (03) :171-354
[8]  
Platt OS, 2002, NEW ENGL J MED, V330, P1639
[9]  
ROSSE WF, 1990, BLOOD, V76, P1431
[10]   Red blood cell exchange: 2015 American Society for Apheresis consensus conference on the management of patients with sickle cell disease [J].
Sarode, Ravi ;
Ballas, Samir K. ;
Garcia, Alicia ;
Kim, Haewon C. ;
King, Karen ;
Sachais, Bruce ;
Williams, Lance A., III .
JOURNAL OF CLINICAL APHERESIS, 2017, 32 (05) :342-367